UBS AM’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-150,039
| Closed | -$1.41M | – | 2699 |
|
|
2024
Q4 | $1.41M | Buy |
150,039
+32,534
| +28% | +$306K | ﹤0.01% | 2212 |
|
|
2024
Q3 | $947K | Sell |
117,505
-21,372
| -15% | -$172K | ﹤0.01% | 2420 |
|
|
2024
Q2 | $1.18M | Buy |
138,877
+74,349
| +115% | +$630K | ﹤0.01% | 2291 |
|
|
2024
Q1 | $579K | Hold |
64,528
| – | – | ﹤0.01% | 2240 |
|
|
2023
Q4 | $725K | Buy |
64,528
+3,113
| +5% | +$35K | ﹤0.01% | 2189 |
|
|
2023
Q3 | $530K | Hold |
61,415
| – | – | ﹤0.01% | 2272 |
|
|
2023
Q2 | $666K | Hold |
61,415
| – | – | ﹤0.01% | 2202 |
|
|
2023
Q1 | $666K | Sell |
61,415
-3,624
| -6% | -$39.3K | ﹤0.01% | 2202 |
|
|
2022
Q4 | $730K | Sell |
65,039
-7,379
| -10% | -$82.8K | ﹤0.01% | 2009 |
|
|
2022
Q3 | $734K | Hold |
72,418
| – | – | ﹤0.01% | 2143 |
|
|
2022
Q2 | $656K | Sell |
72,418
-2,345
| -3% | -$21.2K | ﹤0.01% | 2171 |
|
|
2022
Q1 | $715K | Buy |
74,763
+609
| +0.8% | +$5.82K | ﹤0.01% | 2304 |
|
|
2021
Q4 | $819K | Buy |
74,154
+9,654
| +15% | +$107K | ﹤0.01% | 2313 |
|
|
2021
Q3 | $477K | Buy |
64,500
+579
| +0.9% | +$4.29K | ﹤0.01% | 2524 |
|
|
2021
Q2 | $928K | Buy |
63,921
+3,127
| +5% | +$45.4K | ﹤0.01% | 2253 |
|
|
2021
Q1 | $1.24M | Hold |
60,794
| – | – | ﹤0.01% | 1984 |
|
|
2020
Q4 | $1.08M | Buy |
60,794
+17,366
| +40% | +$309K | ﹤0.01% | 1945 |
|
|
2020
Q3 | $642K | Hold |
43,428
| – | – | ﹤0.01% | 2020 |
|
|
2020
Q2 | $912K | Buy |
43,428
+9,624
| +28% | +$202K | ﹤0.01% | 1849 |
|
|
2020
Q1 | $781K | Buy |
33,804
+47
| +0.1% | +$1.09K | ﹤0.01% | 1790 |
|
|
2019
Q4 | $874K | Buy |
33,757
+6,932
| +26% | +$179K | ﹤0.01% | 1977 |
|
|
2019
Q3 | $523K | Buy |
26,825
+13,696
| +104% | +$267K | ﹤0.01% | 2269 |
|
|
2019
Q2 | $214K | Hold |
13,129
| – | – | ﹤0.01% | 2519 |
|
|
2019
Q1 | $298K | Sell |
13,129
-7,248
| -36% | -$164K | ﹤0.01% | 2320 |
|
|
2018
Q4 | $521K | Buy |
20,377
+3,100
| +18% | +$79.3K | ﹤0.01% | 1978 |
|
|
2018
Q3 | $564K | Buy |
17,277
+8,158
| +89% | +$267K | ﹤0.01% | 2037 |
|
|
2018
Q2 | $207K | Hold |
9,119
| – | – | ﹤0.01% | 2464 |
|
|
2018
Q1 | $221K | Sell |
9,119
-7,958
| -47% | -$193K | ﹤0.01% | 2343 |
|
|
2017
Q4 | $476K | Sell |
17,077
-6,921
| -29% | -$193K | ﹤0.01% | 1996 |
|
|
2017
Q3 | $822K | Buy |
23,998
+3,172
| +15% | +$109K | ﹤0.01% | 1790 |
|
|
2017
Q2 | $830K | Buy |
20,826
+14,107
| +210% | +$562K | ﹤0.01% | 1732 |
|
|
2017
Q1 | $247K | Hold |
6,719
| – | – | ﹤0.01% | 2086 |
|
|
2016
Q4 | $214K | Sell |
6,719
-5,300
| -44% | -$169K | ﹤0.01% | 2093 |
|
|
2016
Q3 | $436K | Hold |
12,019
| – | – | ﹤0.01% | 2056 |
|
|
2016
Q2 | $273K | Buy |
+12,019
| New | +$273K | ﹤0.01% | 2269 |
|
|
2015
Q2 | – | Sell |
-471,712
| Closed | -$8.18M | – | 2724 |
|
|
2015
Q1 | $8.18M | Buy |
471,712
+237,900
| +102% | +$4.13M | 0.01% | 927 |
|
|
2014
Q4 | $3.49M | Buy |
233,812
+3,100
| +1% | +$46.2K | ﹤0.01% | 1135 |
|
|
2014
Q3 | $5.32M | Buy |
230,712
+9,800
| +4% | +$226K | 0.01% | 1021 |
|
|
2014
Q2 | $7.04M | Buy |
+220,912
| New | +$7.04M | 0.01% | 955 |
|